105 related articles for article (PubMed ID: 6973426)
1. Abnormal adherent cell function in aplastic anaemia demonstrated using levamisole in cultures for T lymphocyte colony-forming cells (TL-CFC).
Gordon MY; King JA; Gordon-Smith EC
Clin Exp Immunol; 1981 Apr; 44(1):117-23. PubMed ID: 6973426
[TBL] [Abstract][Full Text] [Related]
2. Effects of levamisole on T lymphocyte colony formation by cells from bone marrow aspirates.
Gordon MY
Clin Exp Immunol; 1981 Aug; 45(2):365-70. PubMed ID: 6976244
[TBL] [Abstract][Full Text] [Related]
3. A characterization of T lymphocyte colony-forming cells (TL-CFC) in human bone marrow.
Swart K; Löwenberg B
Clin Exp Immunol; 1980 Sep; 41(3):541-6. PubMed ID: 6969159
[TBL] [Abstract][Full Text] [Related]
4. The use of a T lymphocyte colony assay to measure mononuclear phagocyte function.
Gordon MY; King JA; Gordon-Smith EC
Clin Exp Immunol; 1980 Oct; 42(1):156-61. PubMed ID: 6970097
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the in vitro colony-forming capacity of human T lymphocytes induced by levamisole.
Pistoia V; Ghio R; Dallegri F; Patrone F
Thymus; 1982 Sep; 4(5):273-8. PubMed ID: 6983744
[TBL] [Abstract][Full Text] [Related]
6. Characterization of stroma-adherent colony-forming cells: a clonogenic assay for early hemopoietic cells?
Tucker D; Bol S; Kannourakis G
Exp Hematol; 1993 Mar; 21(3):469-74. PubMed ID: 8440345
[TBL] [Abstract][Full Text] [Related]
7. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
8. T-lymphocyte colony formation by lymphocytes from patients with aplastic anaemia.
Ennis KT; Morris TC; Irvine AE; Alexander HD
Nat Immun Cell Growth Regul; 1987; 6(1):45-55. PubMed ID: 3494909
[TBL] [Abstract][Full Text] [Related]
9. Immune suppression of hematopoiesis in aplastic anemia: activity of T-gamma lymphocytes.
Bacigalupo A; Podestà M; Mingari MC; Moretta L; Van Lint MT; Marmont A
J Immunol; 1980 Oct; 125(4):1449-53. PubMed ID: 6967904
[TBL] [Abstract][Full Text] [Related]
10. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G
Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
[TBL] [Abstract][Full Text] [Related]
11. [Effect of antithymocyte globulin on bone marrow colony-forming capacity during defective myelopoiesis].
Torubarova NA; Krasina NA; Vladimirskaia EB; Soldatova MA
Biull Eksp Biol Med; 1981 Apr; 91(4):483-5. PubMed ID: 6973376
[TBL] [Abstract][Full Text] [Related]
12. Regulation of self-renewal of human T lymphocyte colony-forming units (TL-CFUs).
Wu AM
J Cell Physiol; 1983 Oct; 117(1):101-8. PubMed ID: 6604730
[TBL] [Abstract][Full Text] [Related]
13. Dependency of human T lymphocyte colony formation on soluble factors produced by accessory or tumor cells.
Winkelstein A
J Immunol; 1983 Jun; 130(6):2715-9. PubMed ID: 6602178
[TBL] [Abstract][Full Text] [Related]
14. In vitro sensitivity to steroid hormones and cytotoxic agents of normal and malignant lymphocyte colony-forming cells.
Taetle R; To D; Mendelsohn J
Cancer Res; 1983 Aug; 43(8):3553-8. PubMed ID: 6602652
[TBL] [Abstract][Full Text] [Related]
15. Severe aplastic anaemia treated with anti-lymphocyte globulin. The relationship between clinical course and erythroid colony suppression by T cells.
Hanada T; Abe T; Fukao K; Jogamoto M; Takita H
Scand J Haematol; 1982 Aug; 29(2):128-34. PubMed ID: 6982505
[TBL] [Abstract][Full Text] [Related]
16. Cellular interactions and IL2 requirements of PHA-induced human T-lymphocyte colonies.
Woods GM; Lowenthal RM
Exp Hematol; 1984 Jun; 12(5):301-8. PubMed ID: 6609832
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the T lymphocyte colony-forming cells and evidence for the acquisition of T cell markers in the absence of the thymic microenvironment in man.
Triebel F; Robinson WA; Hayward AR; de Laforest PG
J Immunol; 1981 May; 126(5):2020-3. PubMed ID: 6971318
[TBL] [Abstract][Full Text] [Related]
18. Identification of a murine high-proliferative-potential colony-forming cell (HPP-CFC) capable of producing a number of megakaryocytes and replating for secondary HPP-CFCs in culture.
Han ZC
J Lab Clin Med; 1994 Apr; 123(4):610-6. PubMed ID: 8145010
[TBL] [Abstract][Full Text] [Related]
19. High-dose granulocyte-colony stimulating factor (G-CSF) in vitro induces the growth of high proliferative potential colony forming cells (HPP-CFC) in patients undergoing blood stem cell mobilization.
Perez-Oteyza J; Ramos P; Testa NG; Heinrichs B; Lopez-Jimenez J; Garcia-Laraña J; Odriozola J
Exp Hematol; 1997 Jun; 25(6):516-20. PubMed ID: 9197330
[TBL] [Abstract][Full Text] [Related]
20. Purification of human peripheral blood colony forming cells (CFUC).
Goldberg J; McGuire LA; Dock NL; Williams WJ; Davey FR
Exp Hematol; 1980 Oct; 8(9):1086-93. PubMed ID: 7014236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
